| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |